Fabrice Beau
- Molecular Biology top 10%
- Oncology top 5%
- Cancer Research top 2%
- Organic Chemistry top 5%
- Hematology top 10%
- Co-authors
- Vincent DiveAthanasios YiotakisLaurent DevelDimitris GeorgiadisBertrand CzarnyPhilippe CuniasseMagdalini MatziariAnastasios Makaritis
- Topics
- Protease and Inhibitor Mechanisms (28 papers)Peptidase Inhibition and Analysis (26 papers)Chemical Synthesis and Analysis (7 papers)
- Journals
- Journal of Biological ChemistryAngewandte Chemie International EditionAdvanced Functional Materials
- Partner nations
- FranceGreeceUnited States
In The Last Decade
Fabrice Beau
48 papers receiving 1.6k citations
Peers
Comparison fields: 5 of 105
- Molecular Biology 821
- Oncology 717
- Cancer Research 652
- Organic Chemistry 370
- Hematology 139
Countries citing papers authored by Fabrice Beau
This map shows the geographic impact of Fabrice Beau's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fabrice Beau with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fabrice Beau more than expected).
Fields of papers citing papers by Fabrice Beau
This network shows the impact of papers produced by Fabrice Beau. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fabrice Beau. The network helps show where Fabrice Beau may publish in the future.
Co-authorship network of co-authors of Fabrice Beau
This figure shows the co-authorship network connecting the top 25 collaborators of Fabrice Beau. A scholar is included among the top collaborators of Fabrice Beau based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fabrice Beau. Fabrice Beau is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 5 | |
| 3 | 0 | |
| 4 | 14 | |
| 5 | 1 | |
| 6 | 7 | |
| 7 | 13 | |
| 8 | 13 | |
| 9 | 22 | |
| 10 | 25 | |
| 11 | 17 | |
| 12 | 31 | |
| 13 | 75 | |
| 14 | 27 | |
| 15 | 38 | |
| 16 | 103 | |
| 17 | 26 | |
| 18 | 78 | |
| 19 | 132 | |
| 20 | 49 |
About Fabrice Beau
Fabrice Beau is a scholar working on Cancer Research, Oncology and Genetics, having authored 49 papers that have together received 1.6k indexed citations. Recurring topics across this work include Protease and Inhibitor Mechanisms (28 papers), Peptidase Inhibition and Analysis (26 papers) and Chemical Synthesis and Analysis (7 papers). The work is most often cited by research in Cancer Research (652 citations), Oncology (717 citations) and Organic Chemistry (370 citations). Fabrice Beau has collaborated with scholars based in France, Greece and United States. Frequent co-authors include Vincent Dive, Athanasios Yiotakis, Laurent Devel, Dimitris Georgiadis, Bertrand Czarny, Philippe Cuniasse, Magdalini Matziari, Anastasios Makaritis, E.A. Stura and Philippe Cuniasse. Their work appears in journals such as Journal of Biological Chemistry, Angewandte Chemie International Edition and Advanced Functional Materials.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.